Yarrow Bioscience, Inc.
YARW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566044
No open-market purchases or sales by Yarrow Bioscience, Inc. insiders were filed in the last 90 days; 46 institutions reported holding it in 13F filings for Q2 2026, worth $8.79M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Yarrow Bioscience, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- 0 vs. Q1 2024
- Shares held
- 7.98M
- +142.9K (+1.8%) vs. Q1 2024
- Total value
- $16.1M
- −$6.80M (−29.7%) vs. Q1 2024
- New holders
- 3
- 12 more added
- Sold out
- 3
- 9 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting YARW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $8.79M |
| Q1 2026 | 46 | $8.49M |
| Q4 2025 | 45 | $5.35M |
| Q3 2025 | 36 | $1.33M |
| Q2 2025 | 46 | $13.4M |
| Q1 2025 | 38 | $11.5M |
| Q4 2024 | 35 | $23.4M |
| Q3 2024 | 33 | $14.3M |
| Q2 2024 | 32 | $16.1M |
| Q1 2024 | 32 | $22.9M |
| Q4 2023 | 33 | $18.4M |
| Q3 2023 | 21 | $1.54M |
| Q2 2023 | 20 | $1.63M |
| Q1 2023 | 23 | $1.10M |
| Q4 2022 | 41 | $1.10M |
| Q3 2022 | 41 | $1.84M |
| Q2 2022 | 41 | $3.25M |
| Q1 2022 | 45 | $5.63M |
| Q4 2021 | 55 | $12.5M |
| Q3 2021 | 65 | $20.1M |
| Q2 2021 | 73 | $64.0M |
| Q1 2021 | 87 | $152.4M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Yarrow Bioscience, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ashton Thomas Private Wealth, LLC | 19 | $37 | 0.00% | +19 | New |
| Wells Fargo & Company | 65 | $128 | 0.00% | −109−62.6% | Reduced |
| JPMorgan Chase & Co | 176 | $347 | 0.00% | +7+4.1% | Added |
| Russell Investments Group, Ltd. | 187 | $368 | 0.00% | 00.0% | Unchanged |
| Centerpoint Advisors, LLC | 350 | $1.00K | 0.00% | +350 | New |
| MB, Levis & Associates, LLC | 1,041 | $2.05K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,799 | $3.54K | 0.00% | −69−3.7% | Reduced |
| Bank of America Corp | 2,306 | $4.54K | 0.00% | +119+5.4% | Added |
| Tower Research Capital LLC (TRC) | 3,383 | $6.67K | 0.00% | +2,142+172.6% | Added |
| Royal Bank of Canada | 4,456 | $9.00K | 0.00% | −170,916−97.5% | Reduced |
| State Street Corp | 15,765 | $31.1K | 0.00% | +4,100+35.1% | Added |
| Lynx1 Capital Management LP | 16,194 | $31.9K | 0.01% | +16,194 | New |
| UBS Group AG | 25,058 | $49.4K | 0.00% | +25,042+156,512.5% | Added |
| Staley Capital Advisers Inc | 36,472 | $71.8K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 37,655 | $74.2K | 0.00% | +704+1.9% | Added |
| Susquehanna International Group, LLP | 60,323 | $118.8K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 60,581 | $119.3K | 0.00% | +15,963+35.8% | Added |
| Renaissance Technologies LLC | 63,111 | $124.3K | 0.00% | −17,465−21.7% | Reduced |
| Prelude Capital Management, LLC | 65,034 | $128.1K | 0.01% | −29,566−31.3% | Reduced |
| Geode Capital Management, LLC | 135,670 | $267.3K | 0.00% | +28,895+27.1% | Added |
| ADAR1 Capital Management, LLC | 171,217 | $337.3K | 0.07% | +61,126+55.5% | Added |
| Schonfeld Strategic Advisors LLC | 216,223 | $426.0K | 0.00% | −3,577−1.6% | Reduced |
| AlphaCentric Advisors LLC | 310,500 | $611.7K | 0.45% | −134,500−30.2% | Reduced |
| Parkman Healthcare Partners LLC | 345,206 | $680.1K | 0.09% | −351,264−50.4% | Reduced |
| Exome Asset Management LLC | 353,434 | $696.3K | 0.62% | −62,000−14.9% | Reduced |
| Vanguard Group Inc | 443,518 | $873.7K | 0.00% | +373,885+536.9% | Added |
| Palo Alto Investors LP | 445,434 | $877.5K | 0.10% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 467,397 | $920.8K | 0.23% | +381,014+441.1% | Added |
| DSC Advisors, L.P. | 696,465 | $1.37M | 4.58% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,211,066 | $2.39M | 0.00% | +29,978+2.5% | Added |
| Cormorant Asset Management, LP | 1,394,336 | $2.75M | 0.16% | 00.0% | Unchanged |
| Eventide Asset Management, LLC | 1,394,336 | $3.13M | 0.05% | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −16,199−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −10,990−100.0% | Sold out |
| Cornerstone Planning Group LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |